Company / Income Tax
Collegium Pharmaceutical, Inc. Income Tax History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$29.7M
FY2025
5-year range
-$74.9M / $29.7M
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
#33 of 204
Health Care
What the data says
Collegium Pharmaceutical, Inc.'s income tax of $30M is higher than 84% of companies in the Health Care sector (FY2025). Income Tax has increased for 4 consecutive years, from -$75M in FY2021 to $30M in FY2025.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of +104.6%. Top quartile in the Health Care sector.
Increased from $28M to $30M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +104.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 204This company $29.7M Sector average $118.7M
▼
-74.9% below sector average
Key checks
Key Insights
- Collegium Pharmaceutical, Inc.'s income tax has grown for 4 consecutive years.
- 5-year CAGR of +104.6%, indicating consistent growth.
- In FY2025, income tax increased 1.3% year-over-year.
- Ranks #33 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.7M | +1.3% |
| FY2024 | $29.4M | +6.5% |
| FY2023 | $27.6M | +817.2% |
| FY2022 | -$3.8M | +94.9% |
| FY2021 | -$74.9M | -9123.0% |
| FY2020 | $830.0K | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026